| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Ocular Therapeutix Inc | |
|---|---|
| Ticker | OCUL |
| CIK # | 0001393434 |
| CUSIP | 67576A100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 36 Crosby Drive Suite 101, Bedford, MA 01730 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Ocular Therapeutix Inc | 2019-03-18 | 37.5 M | Exemption: 506(b) · Duration: One year or less · Finder's Fee: $75,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001393434] | 10-K | |
| [0001393434] | 10-Q | |
| [0001393434] | 3 | |
| [0001393434] | 4 | |
| [0001393434] | 8-K | |
| [0001393434] | D | |
| [0001393434] | SC 13D | |
| [0001393434] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Heier Jeffrey S
Common Stock
|
2026-02-23 | Sell | 3,057 | $8.28 | 25,312 |
|
Kaiser Peter
Common Stock
|
2026-02-23 | Sell | 2,810 | $8.28 | 23,267 |
|
Dugel Pravin
Common Stock
|
2026-02-23 | Sell | 20,056 | $8.28 | 166,064 |
|
Nayak Sanjay
Common Stock
|
2026-02-23 | Sell | 1,759 | $8.28 | 14,565 |
|
Lindstrom Richard L MD
Common Stock
|
2026-02-20 | Buy | 60,229 | $7.66 | 461,354 |
|
Waheed Nadia
Common Stock
|
2026-02-20 | Sell | 3,510 | $7.74 | 27,167 |
|
Notman Donald
Common Stock
|
2026-02-12 | Sell | 11,446 | $9.04 | 103,472 |
|
Dugel Pravin
Common Stock
|
2026-02-12 | Sell | 124,882 | $9.04 | 1,128,933 |
|
Nayak Sanjay
Common Stock
|
2026-02-12 | Sell | 10,348 | $9.04 | 93,546 |
|
Waheed Nadia
Common Stock
|
2026-02-12 | Sell | 7,863 | $9.04 | 71,082 |
|
Notman Donald
Common Stock
|
2026-02-04 | Sell | 6,035 | $8.54 | 51,539 |
|
Notman Donald
Common Stock
|
2026-02-02 | Sell | 5,455 | $9.14 | 49,859 |
|
Robinson David Wayne
Stock Option (Right to Buy) · derivative
|
2026-01-21 | Grant | 416,000 | $0.00 | |
|
Robinson David Wayne
Common Stock
|
2026-01-21 | Grant | 136,000 | $0.00 | |
|
Robins Jason Shand
Stock Option (Right to Buy) · derivative
|
2026-01-20 | Grant | 33,000 | $0.00 | |
|
Heier Jeffrey S
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 240,932 | $0.00 | |
|
Kaiser Peter
Common Stock
|
2026-01-02 | Grant | 79,112 | $0.00 | |
|
Nayak Sanjay
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 197,650 | $0.00 | |
|
Waheed Nadia
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 240,932 | $0.00 | |
|
Kaiser Peter
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 240,932 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 273 | 204,256,433 |
| 2025-12-31 | 254 | 195,769,014 |
| 2025-09-30 | 219 | 190,147,675 |
| 2025-06-30 | 189 | 158,325,614 |
| 2025-03-31 | 199 | 138,198,124 |
| 2024-12-31 | 185 | 134,307,131 |
| 2024-09-30 | 169 | 139,558,217 |
| 2024-06-30 | 151 | 143,608,746 |
| 2024-03-31 | 148 | 112,567,819 |
| 2023-12-31 | 119 | 67,283,797 |
| 2023-09-30 | 114 | 34,492,146 |
| 2023-06-30 | 137 | 37,951,598 |